HOT TOPICS
Clostridium Difficile
Clostridium difficile (C. diff) is a spore-forming, Gram-positive anaerobic bacillus that produces two exotoxins: toxin A and toxin B. Clostridium difficile is shed in feces. Any surface, device, or material that becomes contaminated with feces may serve as a reservoir for the Clostridium difficile spores. Clostridium difficile spores are transferred to patients mainly via the hands of healthcare personnel who have touched a contaminated surface or item. Clostridium difficile infection be prevented in hospitals by the prudent use of antibiotics; the use of contact precautions for patients with known or suspected Clostridium difficile infection; preventing contamination of the hands via glove use and handwashing; and implement an environmental cleaning and disinfection strategy.
- Best Practices for Addressing CDI
-
FDA Approves Treatment for Clostridium difficile Infection
Posted in News
-
Infection Rate at Cooley Dickinson Hospital Drops Following UV Room Disinfection with Xenex System
Posted in News, Disinfection & Sterilization, Environmental Hygiene
-
Combating the C. diff Terrorists on the Loose in Hospitals
Posted in News, Environmental Hygiene, Hand Hygiene
-
Efforts to Control CDI Should Target All Virulent Strains Irrespective of PCR Ribotype
Posted in News
-
Meridian Bioscience Receives FDA Clearance for New Premier C. difficile GDH Assay
Posted in News
-
Penn State, Ganeden Biotech Present New Data on Probiotic and C. diff
Posted in News
-
C. diff Colonization Accompanied by Changes in Gut Microbiota
Posted in News
-
Pharmacy OneSource Announces Free Webinar on C. diff Infection
Posted in News
-
FDA Clears Test for C. difficile
Posted in News